Impact of Insulin-Treated Compared to Non-Insulin-Treated Diabetes Mellitus on Outcome of Percutaneous Coronary Intervention with Drug-Coated Balloons versus Drug-Eluting Stents in De Novo Coronary Artery Disease: The Randomized BASKET-SMALL 2 Trial.
Julia SeegerJochen WöhrleBruno SchellerAhmed FarahMarc-Alexander OhlowNorman MangnerSven Möbius-WinklerDaniel WeilenmannGeorg StachelGregor LeibundgutPeter RickenbacherMarco CattaneoNicole GilgenChristoph KaiserRaban V Jegernull On Behalf Of The Basket-Small InvestigatorsPublished in: Journal of cardiovascular development and disease (2023)
DCB compared to DES for treatment of de novo coronary lesions in diabetic patients was associated with similar rates of MACE and numerically lower need for TVR both for ITDM and NITDM patients.
Keyphrases
- coronary artery disease
- percutaneous coronary intervention
- type diabetes
- newly diagnosed
- end stage renal disease
- phase iii
- glycemic control
- ejection fraction
- coronary artery bypass grafting
- acute myocardial infarction
- coronary artery
- chronic kidney disease
- phase ii
- st elevation myocardial infarction
- cardiovascular events
- open label
- study protocol
- antiplatelet therapy
- prognostic factors
- aortic stenosis
- drug induced
- peritoneal dialysis
- double blind
- emergency department
- atrial fibrillation
- randomized controlled trial
- insulin resistance
- skeletal muscle